S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Eila C. Skinner, MD
University of Southern California
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
98 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- Cancer Centers of Central Florida, Pa
Leesburg, Florida, United States
- Cancer Research Center of Hawaii
Honolulu, Hawaii, United States
- Hawaii Medical Center - East
Honolulu, Hawaii, United States
- Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
- Oncare Hawaii, Incorporated - Kuakini
Honolulu, Hawaii, United States
- Oncare Hawaii, Incorporated - Lusitana
Honolulu, Hawaii, United States
- Queen'S Cancer Institute at Queen'S Medical Center
Honolulu, Hawaii, United States
- Straub Clinic and Hospital, Incorporated
Honolulu, Hawaii, United States
- Tripler Army Medical Center
Honolulu, Hawaii, United States
- Maui Memorial Medical Center
Wailuku, Hawaii, United States
- Pacific Cancer Institute - Maui
Wailuku, Hawaii, United States
- Kapiolani Medical Center at Pali Momi
‘Aiea, Hawaii, United States
- Decatur Memorial Hospital Cancer Care Institute
Decatur, Illinois, United States
- Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois, United States
- Regional Cancer Center at Memorial Medical Center
Springfield, Illinois, United States
- St. Francis Hospital and Health Centers - Beech Grove Campus
Beech Grove, Indiana, United States
- Reid Hospital & Health Care Services
Richmond, Indiana, United States
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas, United States
- Olathe Cancer Center
Olathe, Kansas, United States
- Feist-Weiller Cancer Center at Louisiana State University Health Sciences
Shreveport, Louisiana, United States
- Highland Clinic
Shreveport, Louisiana, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Battle Creek Health System Cancer Care Center
Battle Creek, Michigan, United States
- Mecosta County Medical Center
Big Rapids, Michigan, United States
- Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
- Josephine Ford Cancer Center at Henry Ford Hospital
Detroit, Michigan, United States
- Butterworth Hospital at Spectrum Health
Grand Rapids, Michigan, United States
- Ccop - Grand Rapids
Grand Rapids, Michigan, United States
- Lacks Cancer Center at Saint Mary'S Health Care
Grand Rapids, Michigan, United States
- Mercy General Health Partners
Muskegon, Michigan, United States
- Munson Medical Center
Traverse City, Michigan, United States
- Metro Health Hospital
Wyoming, Michigan, United States
- Billings Clinic - Downtown
Billings, Montana, United States
- Ccop - Montana Cancer Consortium
Billings, Montana, United States
- Hematology-Oncology Centers of the Northern Rockies - Billings
Billings, Montana, United States
- Northern Rockies Radiation Oncology Center
Billings, Montana, United States
- St. Vincent Healthcare Cancer Care Services
Billings, Montana, United States
- St. James Healthcare Cancer Care
Butte, Montana, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2006
- Primary completion
- 30 Nov 2011
- Completion
- 30 Apr 2013
- Last update posted
- 8 Jan 2016
- Registered enrollment
- 58
- Registry id
- NCT00234039
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.